Surmodics Inc (SRDX) 27.47 $SRDX Surmodics IVD Launches

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2016 at 11:57 AM

Surmodics Inc (SRDX) 27.47 $SRDX

Surmodics IVD Launches Breakthrough StabilBlock(R) Immunoassay Stabilizer
BusinessWire - Mon Aug 01, 6:05AM CDT
Surmodics, Inc. (NASDAQ: SRDX), the global leader in chemical components for in vitro diagnostic (IVD) tests and microarrays, has announced the launch and immediate availability of StabilBlock(R), its most advanced Immunoassay Stabilizer. StabilBlock Immunoassay Stabilizer is the best available reagent for reducing non-specific binding to boost immunoassay signal-to-noise ratios.
SRDX: 27.47 (+0.41)

Surmodics Reports Third Quarter Fiscal 2016 Results
BusinessWire - Thu Jul 28, 6:30AM CDT
--GAAP EPS of $0.30, Non-GAAP EPS of $0.37
SRDX: 27.47 (+0.41)

Look at Medical Product Earnings on Jul 28: BSX, RMD & More
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:59AM CDT
Medical is one of the seven broader sectors among the 16 Zacks sectors to report earnings growth this season.
BSX: 24.15 (-0.28), SRDX: 27.47 (+0.41), ZBH: 130.00 (-1.06), VIVO: 19.34 (-0.21), RMD: 69.65 (-0.20)

20.9% Return Seen to Date on SmarTrend SurModics Call (SRDX)
Comtex SmarTrend(R) - Wed Jul 27, 1:16AM CDT
SmarTrend identified an Uptrend for SurModics (NASDAQ:SRDX) on January 28th, 2016 at $20.44. In approximately 6 months, SurModics has returned 20.92% as of today's recent price of $24.71.
SRDX: 27.47 (+0.41)

SurModics Up 17.0% Since SmarTrend Uptrend Call (SRDX)
Comtex SmarTrend(R) - Fri Jul 08, 1:30AM CDT
SmarTrend identified an Uptrend for SurModics (NASDAQ:SRDX) on January 28th, 2016 at $20.44. In approximately 5 months, SurModics has returned 16.96% as of today's recent price of $23.90.
SRDX: 27.47 (+0.41)

Myriad Genetics Buys Sividon Diagnostics, Gains EndoPredict
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 7:59AM CDT
With the global cancer diagnostic market currently expected to grow at a CAGR of 7.6% to $168.6 billion by 2020; we expect the Sividon acquisition to open up more opportunities for Myriad (MYGN) in this market.
BSX: 24.15 (-0.28), SRDX: 27.47 (+0.41), MYGN: 30.54 (-0.94), BAX: 48.29 (-0.21)

SurModics to Present at Jefferies Healthcare Conference
BusinessWire - Wed Jun 01, 7:05AM CDT
SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced that Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of finance and chief financial officer, will make a presentation to the investment community at the Jefferies Healthcare Conference in New York City on Tuesday, June 7, 2016, at 4 p.m. ET (3 p.m. CT).
SRDX: 27.47 (+0.41)

GNC Holdings Q1 Results Weak, Overseas Prospects Bright
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:01AM CDT
GNC Holdings (GNC) made a disappointing start to its first quarter of 2016 with the results squarely missing the Zacks Consensus Estimate.
BSX: 24.15 (-0.28), SRDX: 27.47 (+0.41), BAX: 48.29 (-0.21), GNC: 19.80 (-0.17)

Thermo Fisher to Buy FEI, Boost Electron Microscopy Platform
Zacks Equity Research - Zacks Investment Research - Tue May 31, 7:58AM CDT
The FEI deal is expected to be accretive to Thermo Fisher's (TMO) adjusted EPS by 30 cents in the first full year after close.
BSX: 24.15 (-0.28), SRDX: 27.47 (+0.41), TMO: 156.48 (-3.08), BAX: 48.29 (-0.21), FEIC: 106.57 (+0.12)

IDEXX Laboratories: Strong Instrument Placement Drives Q1
Zacks Equity Research - Zacks Investment Research - Mon May 30, 7:12AM CDT
IDEXX (IDXX) started off 2016 on a strong note, with its first-quarter results squarely beating the Zacks Consensus Estimate.
BSX: 24.15 (-0.28), SRDX: 27.47 (+0.41), BAX: 48.29 (-0.21), IDXX: 106.89 (+13.38)

Cepheid: GeneXpert Placements High, Currency Woes Stay
Zacks Equity Research - Zacks Investment Research - Fri May 27, 6:51AM CDT
Cepheid (CPHD) started 2016 on a promising note with its first-quarter results squarely beating the Zacks Consensus Estimate.
BSX: 24.15 (-0.28), SRDX: 27.47 (+0.41), BAX: 48.29 (-0.21), CPHD: 36.21 (-0.55)

Qiagen, Therawis Diagnostics to Develop Breast Cancer Test
Zacks Equity Research - Zacks Investment Research - Fri May 27, 6:47AM CDT
With the global cancer diagnostic market expected to grow at a CAGR of 7.6% to $168.6 billion by 2020, we expect Qiagen (QGEN) to garner higher profits on account of this collaboration.
BSX: 24.15 (-0.28), SRDX: 27.47 (+0.41), BAX: 48.29 (-0.21), QGEN: 26.68 (-0.12)

ResMed Posts Mixed Q3 Results, Brightree Buyout on Track
Zacks Equity Research - Zacks Investment Research - Thu May 26, 7:35AM CDT
ResMed (RMD) posted a lackluster third-quarter fiscal 2016. Nevertheless, ResMed's segmental as well as geographical performance was strong.
BSX: 24.15 (-0.28), SRDX: 27.47 (+0.41), BAX: 48.29 (-0.21), RMD: 69.65 (-0.20)

ResMed: Positive CAT-HF Study Results to Drive ASV Sales
Zacks Equity Research - Zacks Investment Research - Wed May 25, 7:51AM CDT
The positive CAT-HF study results encourage us to expect a rise in demand for the wide range of products offered by ResMed (RMD) in the respiratory care market.
BSX: 24.15 (-0.28), SRDX: 27.47 (+0.41), BAX: 48.29 (-0.21), RMD: 69.65 (-0.20)

Edwards Lifesciences: Q1 Strong, TAVR Prospects Bright
Zacks Equity Research - Zacks Investment Research - Wed May 25, 7:50AM CDT
Edwards Lifesciences (EW) made a strong start to 2016, with its first-quarter results beating estimates on both the fronts.
BSX: 24.15 (-0.28), SRDX: 27.47 (+0.41), BAX: 48.29 (-0.21), EW: 113.26 (-0.97)

Baxter Unveils THERANOVA Dialyser at ERA-EDTA Congress
Zacks Equity Research - Zacks Investment Research - Wed May 25, 7:42AM CDT
Baxter International Inc. (BAX) recently showcased THERANOVA, a new class of medium cut-off (MCO) dialysers.
SRDX: 27.47 (+0.41), IRMD: 17.68 (-1.40), MASI: 52.69 (-0.24), BAX: 48.29 (-0.21)

Baxter (BAX) Raised to Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Fri May 20, 8:22AM CDT
On May 20, Zacks Investment Research raised Baxter International Inc. (BAX) to a Zacks Rank #1 (Strong Buy).
SRDX: 27.47 (+0.41), MASI: 52.69 (-0.24), BAX: 48.29 (-0.21), EW: 113.26 (-0.97)

Quality Systems (QSII) Q4 Earnings Disappoint, Stock Falls
Zacks Equity Research - Zacks Investment Research - Fri May 20, 8:21AM CDT
Shares of Quality Systems Inc. (QSII) plunged almost 10% in after-hours trading following the company's disappointing fourth-quarter fiscal 2016 results.
SRDX: 27.47 (+0.41), MASI: 52.69 (-0.24), EW: 113.26 (-0.97), QSII: 12.04 (-0.16)

Boston Scientific's Full-Body MRI SCS System Gets FDA Nod
Zacks Equity Research - Zacks Investment Research - Fri May 20, 8:20AM CDT
Boston Scientific's (BSX) Precision Montage MRI SCS allows patients to undergo a full-body 1.5 Tesla MRI scan while also delivering multiple waveforms.
BSX: 24.15 (-0.28), SRDX: 27.47 (+0.41), BAX: 48.29 (-0.21), LMAT: 17.30 (-0.59)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

New Podcast by Paralyzed Veterans of America Offers Unique Insights

Empowering Veterans Through Storytelling Some stories don't just rattle around in your headphones—they stick with you. The 'Voices of PVA' podcast, launched by Paralyzed Veterans of America, aims to do exactly that. It's not just a podcast; it's a platform where voices of veterans and people with spinal cord injuries like MS and ALS aren't just heard, they're amplified....

Miguel Pantoja: Wiring a Second Chance Beyond Bars

A Second Shot with Electric Dreams Miguel Pantoja, once on the rocky road of life choices, now lights up Northern California with his spark — quite literally. Walking out of federal prison, his mind was set as firmly as a bolt: first stop was a burger, second was a plan to transform his past into a new beginning. That path took him to UEI College in Sacramento, where...

Clarius Named in TIME's Top HealthTech 2026 Again

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Sequel Advisors Rebrand: Founder-Centric M&A Focus

What's in a Name? A Shift to Reflect Reality When a company decides it's time to shake things up with a rebrand, they better have a good reason. Enter what's now called Sequel Advisors—shedding the old label, Transact Capital, to let founders know exactly what they’re dealing with upfront. This isn't just some slick, new logo on a letterhead. It's about aligning their...

Rise Treatment Center Launches in Vegas for Teens

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Wrensilva Unveils Studio Console in White Oak

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

Microplastics Webinar: Navigating Complex Regulations

Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...

Seatrium, Karpowership Wrap Landmark FSRU Partnership

A Milestone in Global Energy Infrastructure Out of Admiralty Yard in Singapore comes a transformation saga that’s begging for attention. Seatrium Limited and Karpowership have pulled off something spectacular with their seventh and final Floating Storage and Regasification Unit (FSRU), LNGT Türkiye. It's not just another vessel hitting the waters—it's the bookend on...

NSF Backs New Space Projects: Cooling & Drug Delivery

You know, every time we think we're at the edge of current science, space reminds us how little we actually know. From the International Space Station up there in low Earth orbit, fresh experiments are kicking off to change what we understand about electronics cooling and drug delivery. It's a classic scenario of reaching for the stars to help us out back here on Earth....

Spotlight on AI-Powered Smart Homes for 2027

Gearing Up for the Connected Home Revolution Ah, the thrill of peering into the future of smart homes! That's what's cookin' as Parks Associates gears up for its annual CONNECTIONS™ Conference slated for May 4-6, 2027. This isn't just another routine pow-wow. Nope, this get-together is about seeing who's leading the pack in transforming our everyday spaces into...